<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41025">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02572310</url>
  </required_header>
  <id_info>
    <org_study_id>STR HVC</org_study_id>
    <nct_id>NCT02572310</nct_id>
  </id_info>
  <brief_title>Simplex High Viscosity Bone Cement in Primary Total Knee Arthroplasty</brief_title>
  <official_title>A Prospective Radiostereometric Analysis (RSA) Study of Implant Stability and Clinical Evaluation of Simplex High Viscosity Bone Cement in Primary Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Michael Dunbar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nova Scotia Health Authority</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators propose to monitor subjects who have received Triathlon
      total knee components inserted with HV cement. The primary outcome will be fixation of the
      tibial implant component as assessed with RSA and to determine the functionality of patients
      after surgery using self-reported questionnaires. This is a historical control study,
      comparing the study cohort to a previous group with Triathlon implants and the long-standing
      Simplex T cement. The secondary outcomes are inducible displacements of the implants as well
      as a qualitative evaluation of the cement handling characteristics performed by the
      operating room staff.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Implant Migration measured with Radiostereometric Analysis (RSA)</measure>
    <time_frame>2 years</time_frame>
    <description>Total implant migration will be measured in mm using RSA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Qualitative handling characteristics captured through semi-structured interviews</measure>
    <time_frame>intra-operative</time_frame>
    <description>A qualitative methodology will be used to perform content analysis of the audio from the interviews stored in computer-assisted qualitative data analysis software. The content analysis will involve the use of a deductive approach to the interviews. The coding strategies will derived from a predetermined list of important qualities of bone cement and common themes will be identified as important for the usability of the new cement.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>HV Cement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Simplex High Viscosity Bone Cement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Simplex High Viscosity Bone Cement</intervention_name>
    <description>high viscosity bone cement for total knee replacement</description>
    <arm_group_label>HV Cement</arm_group_label>
    <other_name>HV Bone Cement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic arthritis of the knee indicating primary total knee arthroplasty

          -  Between the ages of 21 and 80 inclusive

          -  Patients willing and able to comply with follow-up requirements and self-evaluations

          -  Ability to give informed consent

        Exclusion Criteria:

          -  Active or prior infection

          -  Medical condition precluding major surgery

          -  Severe osteoporosis or osteopenia

          -  Neuromuscular impairment

          -  Significant co-morbidity affecting ability to ambulate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Dunbar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nova Scotia Health Authority</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elise Laende, MASc</last_name>
    <phone>902-473-3883</phone>
    <email>elise.laende@nshealth.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Dunbar, PhD</last_name>
    <phone>902-473-7997</phone>
    <email>michael.dunbar@nshealth.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nova Scotia Health Authority</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elise Laende</last_name>
      <phone>902-473-3883</phone>
    </contact>
    <investigator>
      <last_name>Michael Dunbar</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Glen Richardson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 4, 2016</lastchanged_date>
  <firstreceived_date>August 19, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nova Scotia Health Authority</investigator_affiliation>
    <investigator_full_name>Michael Dunbar</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
